Vapotherm, Inc. (NYSE:VAPO) Director Lance A. Berry Acquires 95,238 Shares of Stock

Vapotherm, Inc. (NYSE:VAPO – Get Rating) Director Lance A. Berry acquired 95,238 shares of the company’s stock in a transaction dated Friday, February 10th. The shares were bought at an average cost of $1.05 per share, with a total value of $99,999.90. Following the purchase, the director now owns 134,887 shares of the company’s stock, valued at approximately $141,631.35. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Vapotherm Stock Performance

NYSE:VAPO opened at $0.93 on Wednesday. The firm has a market cap of $26.52 million, a PE ratio of -0.22 and a beta of -1.13. Vapotherm, Inc. has a fifty-two week low of $0.46 and a fifty-two week high of $16.39. The company has a debt-to-equity ratio of 7.04, a quick ratio of 2.03 and a current ratio of 3.88. The business has a 50 day moving average price of $1.79 and a 200-day moving average price of $1.60.

Get Vapotherm alerts:

Institutional Trading of Vapotherm

Institutional investors have recently made changes to their positions in the stock. Cambridge Investment Research Advisors Inc. boosted its stake in shares of Vapotherm by 28.9% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 45,558 shares of the company’s stock valued at $115,000 after purchasing an additional 10,208 shares during the period. Trek Financial LLC purchased a new stake in shares of Vapotherm during the second quarter valued at approximately $69,000. Parian Global Management LP boosted its stake in shares of Vapotherm by 3.0% during the second quarter. Parian Global Management LP now owns 1,368,575 shares of the company’s stock valued at $3,462,000 after purchasing an additional 40,466 shares during the period. First Affirmative Financial Network bought a new position in shares of Vapotherm during the fourth quarter valued at approximately $40,000. Finally, Wedmont Private Capital bought a new position in shares of Vapotherm during the fourth quarter valued at approximately $31,000. Hedge funds and other institutional investors own 59.02% of the company’s stock.

Vapotherm Company Profile

(Get Rating)

Vapotherm, Inc is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. Its products include Precision Flow, Precision Flow Heliox, Oxygen Assist Module, Nitric Oxidie Disposable Patient Circuit, Tracheostomy Adapter, and Aerogen Adapter.

Featured Articles

• Get a free copy of the StockNews.com research report on Vapotherm (VAPO)
• LCI Industries Diversification Strategy Pays Off
• Is It Time To Buy The Dip In The Coca-Cola Company 
• Ex-Dividend Date vs. Record Date: What’s the Difference?
• How Does the Consumer Price Index Affect the Stock Market?
• Are Denny’s Corporation Investors Due For A Grand Slam?

Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.